Acorda Therapeutics Inc

A lagger security in the Health Care that looks (login to see)

Yahoo! Profile

ACOR

Biological Product (except Diagnostic) Manufacturing
Weighting

Balanced Growth

Lead | Lag

Bottom Growth

Options

Buying (1.00)

P/E Ratio

0.97

Free Cash Flow

Negative (-0.59)

Dividend

none

Begin Today!

Have access to custom plans you can create, auto-portfolios and much more!




NO OBLIGATION TO BUY